Evaluating the Safety of Tenofovir Vaginal Gel in HIV-Uninfected Pregnant Women

NCT01490671 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: 1% tenofovir gel
DRUG: Placebo gel

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)